Advos

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) has positioned itself at the forefront of cancer treatment innovation with LB-100, the world's first and only clinical-stage inhibitor of protein phosphatase 2A (PP2A). This proprietary small-molecule compound represents a potential new treatment paradigm designed to enhance ...

The creative small business sector demonstrates continued resilience with stable performance and consistent consumer demand, according to the 2026 Small Business Creatives Outlook Report released by ACT Insurance. The report, which combines survey data from ACT-insured businesses and U.S. consumers with proprietary claims a...

GPS jamming has emerged as a key modern warfare tactic, using high-powered radio signals to disrupt satellite navigation and shape both offensive operations and defensive countermeasures on the battlefield. This development creates significant concern for military organizations worldwide, as numerous aspects of contemporary...

Datavault AI Inc. (NASDAQ: DVLT) has entered into a definitive agreement with Coppercore Inc. to launch a $100 million copper tokenization initiative. The program will utilize Datavault AI's proprietary blockchain platform to create Coppercoin digital tokens, with each token representing five pounds of in-ground copper. Pri...

Carlos Iafigliola, Interim President of Amerant Bank, appears on the cover of Negocios Magazine's latest edition, discussing the bank's strategic direction during a transitional period. With nearly $10 billion in assets and over 40 years of history, Amerant Bank has established itself as Florida's largest community bank, ma...

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) has acknowledged its partner Hastings Technology Metals, alongside Wyloo, for acquiring a fully permitted mixed rare earth chloride production facility in Thailand. This acquisition is expected to accelerate near-term processing of monazite feedstock and strengthen a Wester...

Telomir Pharmaceuticals has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for its candidate Telomir-1, targeting advanced and metastatic triple-negative breast cancer. The submission is supported by preclinical data demonstrating tumor growth reduction and favorable tolerability ...

A research collaboration between Texas Children's Hospital, University of Pittsburgh, and Baylor College of Medicine has identified the primary driver of posterior fossa type A (PFA) ependymoma, one of the deadliest pediatric brain cancers. The scientists discovered that male sex hormones called androgens play a crucial rol...

Copper prices dropped by over 1% late last week to $5.43 per pound, extending a decline that has seen the red metal's value fall more than 16% from its January peak. According to analysis from Macquarie, this correction reflects fundamental market realities rather than temporary fluctuations, with the bank's analysts conclu...

Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across...

The ongoing conflict in Iran has exposed fundamental differences in how nations worldwide are approaching the transition from fossil fuels to renewable energy sources. According to analysis from GreenEnergyStocks, the crisis demonstrates that countries are moving at entirely different speeds, facing unique obstacles, and ex...

French tire manufacturer Michelin has developed new tires specifically designed to enhance the driving range of electric vehicles, potentially addressing one of the most significant barriers to widespread EV adoption. The announcement comes as electric vehicle manufacturers globally seek technological advancements to improv...

New research indicates that the growing number of electric vehicles on roads could exert downward pressure on gasoline prices, benefiting both EV owners and drivers of traditional fossil fuel-powered cars. This development represents a significant economic implication of the ongoing transportation transition beyond environm...

NextPlat Corp (NASDAQ: NXPL, NXPLW) reported full-year 2025 revenue of approximately $54.3 million, representing an 18% decrease compared to the previous year. The company attributed this decline primarily to reduced healthcare prescription volumes, though this was partially offset by growth in e-commerce sales and higher-m...

Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across...

Surging oil prices are reshaping buying decisions for millions of drivers worldwide, creating a significant opportunity for Chinese electric vehicle manufacturers. Geopolitical instability across the Middle East has pushed crude oil above $100 per barrel, unsettling fuel markets and prompting consumers to reconsider their t...

Cybersecurity stocks faced substantial declines on March 27 following reports that artificial intelligence company Anthropic is testing a new AI system with advanced cyber capabilities. The market reaction demonstrates growing investor apprehension about how rapidly evolving AI technologies might disrupt traditional cyberse...

Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced a $100,000 strategic investment in General Astronautics, a space robotics company selected for Y Combinator's Winter 2026 cohort, at a $40 million post-money valuation. The company stated that General Astronautics is developing autonomous robotic systems...

Annovis Bio Inc. (NYSE: ANVS) announced the publication of an article in The Scientist detailing the discovery and development of its lead drug candidate buntanetap, as the company advances ongoing Phase 3 and extension studies in Alzheimer's disease and Parkinson's disease. The article provides historical and scientific co...